In view of the above, we studied the tumour transcriptional activity of HER and vascular endothelial growth factor (VEGF/VEGFR) pathways at the occurrence of locoregional recurrence, retrospectively examined associations with clinicopathological characteristics and analyzed their utility for predicting patient outcome following relapse. This evidence concerns the gene KDR and neoplasm.